• The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • NLS Member
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 03 2017

Malin Otmani

-

September 1, 2017

Share article on X
Share article on Linkedin

Updated: February 3, 2025, 02:36 pm

Published: September 1, 2017

Top stories

Biotech Business – August 21, 2026

Hansa Biopharma prepares for US listing

The company has announced confidential submission of draft registration statement to the SEC to allow for a potential listing of ADSs in the United States.

MedTech Business – August 21, 2026

Implantica receives FDA approval for RefluxStop

The FDA has granted Premarket Approval (PMA) for RefluxStop, the company’s implant-based treatment for gastroesophageal reflux disease (GERD).

Agreement – August 21, 2026

Akiram and ITM sign lutetium-177 supply agreement

Swedish biotech company Akiram Therapeutics has signed an agreement with ITM Isotope Technologies Munich to supply non-carrier-added lutetium-177 for the clinical development of AKIR001.

Financing – August 21, 2026

Eyedentity closes funding round led by Norrsken Launcher

Eyedentity, a company in the Karolinska Institutet Innovation Incubator, has closed an oversubscribed investment round led by Norrsken Launcher.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Biotech Business - August 21, 2026

Hansa Biopharma prepares for US listing

The company has announced confidential submission of draft registration statement to the SEC to allow for a potential listing of ADSs in the United States.

MedTech Business - August 21, 2026

Implantica receives FDA approval for RefluxStop

The FDA has granted Premarket Approval (PMA) for RefluxStop, the company’s implant-based treatment for gastroesophageal reflux disease (GERD).

Agreement - August 21, 2026

Akiram and ITM sign lutetium-177 supply agreement

Swedish biotech company Akiram Therapeutics has signed an agreement with ITM Isotope Technologies Munich to supply non-carrier-added lutetium-177 for the clinical development of AKIR001.

Financing - August 21, 2026

Eyedentity closes funding round led by Norrsken Launcher

Eyedentity, a company in the Karolinska Institutet Innovation Incubator, has closed an oversubscribed investment round led by Norrsken Launcher.

Financing - August 20, 2026

Pixelgen Technologies raises USD 15.5 million

Pixelgen Technologies has closed an oversubscribed USD 15.5 million Series B financing to accelerate global commercialization of its Proxiome Kit and expand the company’s presence in key markets.

Clinical Trials - August 20, 2026

Merck, Moderna report positive melanoma trial results

Merck and Moderna have reported positive topline results from the Phase 3 INTerpath-001 trial of intismeran autogene in combination with Keytruda in patients with completely resected, high-risk melanoma.

Financing - August 20, 2026

Lundbeck reports 16% revenue growth in first half of 2026

The company reported a 16% increase in revenue at constant exchange rates in the first six months of 2026, driven mainly by continued growth in Vyepti and Rexulti.

Sign up to our newsletter: Nordic Life Science News!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.